Characteristics of Clinical Trials Registered in ClinicalTrials.gov, 2007-2010

Cited by (517)

Items 101–200 of 517

1. Characteristics of Ophthalmology Trials Registered in ClinicalTrials.gov, 2007-2018
   Brandon E. Turner, Nitya Rajeshuni, Elaine Tran, Cassie Ann Ludwig, Zujaja Tauqeer, Brannon T. Weeks, Benyam Kinde, Suzann Pershing · 2019 · American Journal of Ophthalmology
2. The significance of the trial outcome was associated with publication rate and time to publication
   Song, Seung Yeon, Koo, Dong-Hoe, Jung, Sun-Young, Kang, Wonku, Kim, Eun Young · 2017 · Journal of Clinical Epidemiology
3. Consent document translation expense hinders inclusive clinical trial enrolment
   Maria A. Velez, Beth A. Glenn, Maria De Lourdes Garcia-Jimenez, Amy Lauren Cummings, Aaron Elliott Lisberg, Andrea Nañez, Yazeed Radwan, Jackson P Lind-Lebuffe, Paige M Brodrick, Debory Li et al. · 2023 · Nature
4. Patient Enrollment to Industry-Sponsored Versus Federally-Sponsored Cancer Clinical Trials
   Joseph M. Unger, Hong Xiao, Riha Vaidya, Michael Leo LeBlanc · 2024 · Journal of Clinical Oncology
5. The State of Infectious Diseases Clinical Trials: A Systematic Review of ClinicalTrials.gov
   Neela D. Goswami, Christopher D. Pfeiffer, John R. Horton, Karen Chiswell, Asba Tasneem, Ephraim L. Tsalik · 2013 · PLoS ONE
6. Characteristics of pediatric cardiovascular clinical trials registered on ClinicalTrials.gov
   Kevin D. Hill, Karen Chiswell, Robert M. Califf, Gail Denise Pearson, Jennifer S. Li · 2014 · American Heart Journal
7. Adult patient perspectives on clinical trial result reporting: A survey of cancer patients
   Kate E. Elzinga, Omar Farooq Khan, Andrew R Tang, Conrad Vincent Fernandez, Christine L Elzinga, Daniel YC Heng, Michael M. Vickers, Tony H. Truong, Patricia A. Tang · 2016 · Clinical Trials
8. When birds of a feather don't flock together: Diversity and innovation outcomes in international R&D collaborations
   Federica Brunetta, Lucia Marchegiani, Enzo Peruffo · 2019 · Journal of Business Research
9. Influence and management of conflicts of interest in randomised clinical trials: qualitative interview study
   Østengaard, Lasse, Lundh, Andreas, Tjørnhøj-Thomsen, Tine, Abdi, Suhayb, Gelle, Mustafe H A, Stewart, Lesley A, Boutron, Isabelle, Hróbjartsson, Asbjørn · 2020 · BMJ
10. Practical characteristics of adaptive design in phase 2 and 3 clinical trials
    Akira Sato, Masashi Shimura, Masahiko Gosho · 2017 · Journal of Clinical Pharmacy and Therapeutics
11. A review of pragmatic trials found a high degree of diversity in design and scope, deficiencies in reporting and trial registry data, and poor indexing
    Stuart Gordon Nicholls, Kelly A. Carroll, Spencer Phillips Hey, Merrick Zwarenstein, Jennifer Zhe Zhang, Hayden P. Nix, Jamie Brehaut, Joanne E. McKenzie, Steve J McDonald, Charles Weijer et al. · 2021 · Journal of Clinical Epidemiology
12. Trends in mental health clinical research: Characterizing the ClinicalTrials.gov registry from 2007–2018
    Joshua R. Wortzel, Brandon E. Turner, Brannon T. Weeks, Christopher Fragassi, Virginia Ramos, Thanh Truong, Desiree Li, Omar Sahak, Hochang Benjamin Lee · 2020 · PLoS ONE
13. Benefits of Streamlined Point-of-Care Trial Designs
    Robert M. Califf, Patrizia A. Cavazzoni, Janet Woodcock · 2022 · JAMA Internal Medicine
14. The current status of clinical trials on cancer and age disparities among the most common cancer trial participants
    Shuang Zhao, Miao Miao, Qingqing Wang, Haijuan Zhao, Han Yang, Xin Wang · 2024 · BMC Cancer
15. Protocol registration and selective outcome reporting in recent psychiatry trials: new antidepressants and cognitive behavioural therapies
    Shinohara, K., Tajika, A., Imai, H., Takeshima, N., Hayasaka, Y., Furukawa, T. A. · 2015 · Acta Psychiatrica Scandinavica
16. Characteristics of clinical trial websites: information distribution between ClinicalTrials.gov and 13 primary registries in the WHO registry network
    Daisuke Ogino, Kunihiko Takahashi, Hajime Satō · 2014 · Trials
17. Adherence to guidance on registration of randomised controlled trials published in Anaesthesia
    Kariem El‐Boghdadly, Matthew D. Wiles, S. Atton, Craig R. Bailey · 2018 · Anaesthesia
18. Influence of pilot and small trials in meta-analyses of behavioral interventions: a meta-epidemiological study
    Michael W. Beets, Robert Glenn Weaver, John P. A. Ioannidis, Christopher D. Pfledderer, Alexis Jones, Lauren von Klinggraeff, Bridget Armstrong · 2023 · Systematic Reviews
19. Academia–Industry Partnerships: Are we ready for new models of partnership?
    Denis Lacombe, Susen Burock, Françoise Meunier · 2012 · European Journal of Cancer
20. Characterisation of digital therapeutic clinical trials: a systematic review with natural language processing
    Brenda Y. Miao, Madhumita Sushil, Ava Xu, Michelle Wang, Douglas V. Arneson, Ellen Berkley, Meera Subash, Rohit Vashisht, Vivek Ashok Rudrapatna, Atul Janardhan Butte · 2024 · The Lancet Digital Health
21. Pragmatic clinical trials: Emerging challenges and new roles for statisticians
    Robert M. Califf · 2016 · Clinical Trials
22. Updated analysis of pediatric clinical studies registered in ClinicalTrials.gov, 2008–2019
    Yang Zhong, Xingyu Zhang, Lijun Jane Zhou, Lei Li, Tao Zhang · 2021 · BMC Pediatrics
23. Large streamlined trials in cardiovascular disease
    Gonzalo Calvo, John J.V. McMurray, Christopher Bull Granger, Andrés Alonso-García, Paul W. Armstrong, Marcus D Flather, Antonio Gómez‐Outes, Stuart Pocock, Norman Stockbridge, Anders Erik Svensson et al. · 2014 · European Heart Journal
24. Current challenges in health economic modeling of cancer therapies: a research inquiry.
    Jeffrey D. Miller, Kathleen A. Foley, Mason W. Russell · 2014 · PubMed Central
25. Clinical adoption of virtual reality in mental health is challenged by lack of high-quality research
    Benjamin Selaskowski, Annika Wiebe, Kyra Kannen, Laura Asché, Julian Pakos, Alexandra Philipsen, Niclas Braun · 2024 · npj Mental Health Research
26. Authors' Self-Declared Financial Conflicts of Interest Do Not Impact the Results of Major Cardiovascular Trials
    Ashish Aneja, Ricardo Esquitin, Kshitij Shah, Rupa L. Iyengar, Rosane A. Nisenbaum, Magda Nunes de Melo, Shiny Mathewkutty, Sanjum S. Sethi, Muhammad Mamdani, Michael E. Farkouh · 2013 · Journal of the American College of Cardiology
27. The Future of Cardiovascular Clinical Research
    Robert M. Califf, Iain C. Sanderson, Marie Lynn Miranda · 2012 · JAMA
28. Understanding the functions and operations of data monitoring committees: Survey and focus group findings
    Karim A. Calis, Patrick Archdeacon, Raymond P. Bain, Annemarie Forrest, Jane Perlmutter, David L. DeMets · 2016 · Clinical Trials
29. Previously unidentified duplicate registrations of clinical trials: an exploratory analysis of registry data worldwide
    Gert van Valkenhoef, Russell F. Loane, Deborah A. Zarin · 2016 · Systematic Reviews
30. Characteristics of mental health trials registered in ClinicalTrials.gov.
    Katherine D. Arnow, A. King, T. Wagner · 2019 · Psychiatry Research
31. From Nonclinical Research to Clinical Trials and Patient-registries: Challenges and Opportunities in Biomedical Research
    J. M. de la Torre Hernández, E. Edelman · 2017 · Revista Española de Cardiología
32. Benign Biological Interventions to Reduce Offending
    Olivia Choy, Farah Focquaert, Adrian Raine · 2018 · Neuroethics
33. Current state of clinical trials in breast cancer brain metastases
    Jawad Fares, Deepak Kanojia, Álex Cordero, Aida Rashidi, Jason M. Miska, Charles W Schwartz, Solomiia Savchuk, Atique U. Ahmed, Irina V. Balyasnikova, Massimo Cristofanilli et al. · 2019 · Neuro-Oncology Practice
34. Diagnostic Clinical Trials in Breast Cancer Brain Metastases: Barriers and Innovations
    Jawad Fares, Deepak Kanojia, Aida Rashidi, Atique U. Ahmed, Irina V. Balyasnikova, Maciej S. Lesniak · 2019 · Clinical Breast Cancer
35. The obstetrical research landscape: a cross-sectional analysis of clinical trials from 2007-2020
    Jecca Rhea Steinberg, Brannon T. Weeks, Griselda Reyes, Alison Conway Fitzgerald, Wendy Y. Zhang, Sarah E. Lindsay, Jill N. Anderson, Katelyn S. Chan, Michael Taylor Richardson, Christopher J. Magnani et al. · 2020 · American Journal of Obstetrics & Gynecology MFM
36. Classifying Drug Ratings Using User Reviews with Transformer-Based Language Models
    Akhil Shiju, Zhe He · 2022 · IEEE International Conference on Healthcare Informatics (ICHI)
37. Characteristics of Artificial Intelligence Clinical Trials in the Field of Healthcare: A Cross-Sectional Study on ClinicalTrials.gov
    Anran Wang, Xiaolei Xiu, Shengyu Liu, Qing Qian, Sizhu Wu · 2022 · International Journal of Environmental Research and Public Health
38. Global shortage of neonatal and paediatric antibiotic trials: rapid review
    Georgina Thompson, Charlotte I. S. Barker, Laura Folgori, Julia Anna Bielicki, John S. Bradley, Irja Lutsar, Mike Sharland · 2017 · BMJ Open
39. Are citations from clinical trials evidence of higher impact research? An analysis of ClinicalTrials.gov
    Mike A Thelwall, Kayvan Kousha · 2016 · Scientometrics
40. Sample sizes in dosage investigational clinical trials: a systematic evaluation
    Jihan Huang, Qianmin Su, Juan Yang, Yinghua Lv, Yingchun He, Junchao Chen, Ling Xu, Kun Wang, Qingshan Zheng · 2015 · Drug Design Development and Therapy
41. Comparison of registered and published primary outcomes in randomized controlled trials of gastroenterology and hepatology
    Xiaoqian Li, Geliang Yang, Kunming Tao, Huiqing Zhang, Qing-Hui Zhou, Changquan Ling · 2013 · Scandinavian Journal of Gastroenterology
42. Clinical Trials Focusing on Drug Control and Prevention of Ventilator-Associated Pneumonia: A Comprehensive Analysis of Trials Registered on ClinicalTrials.gov
    Lingmin Chen, Yanling Su, Liuliu Quan, Yonggang Zhang, Liang Du · 2019 · Frontiers in Pharmacology
43. Surgical trials and trial registers: a cross-sectional study of randomized controlled trials published in journals requiring trial registration in the author instructions
    Julia Hardt, Maria‐Inti Metzendorf, Joerg J Meerpohl · 2013 · Trials
44. Systematic review of the methodological quality of controlled trials evaluating Chinese herbal medicine in patients with rheumatoid arthritis
    Xin Pan, Maria Angeles Lopez-Olivo, Juhee Song, Gregory F. Pratt, Maria Eugenia Suarez-Almazor · 2017 · BMJ Open
45. Respiratory Tract Infection Clinical Trials from 2007 to 2012. A Systematic Review of ClinicalTrials.gov
    Marcus D. Ruopp, Karen Chiswell, Joshua T. Thaden, Kunal Merchant, Ephraim L. Tsalik · 2015 · Annals of the American Thoracic Society
46. Overview of Clinical Trials on Type 2 Diabetes Mellitus: A Comprehensive Analysis of the ClinicalTrials.gov Database
    Jianyan Long, Ruiming Liang, Qiuyi Zheng, Gang Yuan, Ziyi Xin, Xinwen Chen, Fenghua Lai, Yihao Liu · 2021 · Diabetes Metabolic Syndrome and Obesity
47. Evaluation of Oncology Trial Results Reporting Over a 10-Year Period
    Xu Liu, Yuan Zhang, Wen‐Fei Li, Everett E. Vokes, Ying Hao Sun, Quynh‐Thu Le, Jun Ma · 2021 · JAMA Network Open
48. Sponsorship and design characteristics of trials registered in ClinicalTrials.gov
    Dina Roumiantseva, Simona Carini, Ida Sim, Todd H. Wagner · 2013 · Contemporary Clinical Trials
49. Effects of intense assessment on statistical power in randomized controlled trials: simulation study on depression.
    Schuster, Raphael, Schreyer, Manuela Larissa, Kaiser, Tim, Berger, Thomas, Klein, Jan Philipp, Moritz, Steffen, Laireiter, Anton-Rupert, Trutschnig, Wolfgang · 2020 · Internet Interventions
50. Clinical Research in Surgical Oncology: An Analysis of ClinicalTrials.gov
    Amber S. Menezes, Alison Barnes, Adena Sarah Scheer, Guillaume Martel, Husein Moloo, Robin P. Boushey, Elham Sabri, Rebecca C. Auer · 2013 · Annals of Surgical Oncology
51. Clinical Trials Affected by Research Grant Terminations at the National Institutes of Health
    Vishal R. Patel, Michael Liu, Anupam Bapu Jena · 2025 · JAMA Internal Medicine
52. Redundant, Secretive, and Isolated: When Are Clinical Trials Scientifically Valid?
    Kirstin Borgerson · 2014 · Kennedy Institute of Ethics journal
53. Missing diversity in brain tumor trials
    Birra R. Taha, Graham M. Winston, Umberto Tosi, Benjamin Rush Hartley, Caitlin E. Hoffman, Nadia Dahmane, Christopher E. Mason, Jeffrey Peter Greenfield · 2020 · Neuro-Oncology Advances
54. Rise of Clinical Studies in the Field of Machine Learning: A Review of Data Registered in ClinicalTrials.gov
    Claus Zippel, Sabine Bohnet-Joschko · 2021 · International Journal of Environmental Research and Public Health
55. ‘Optimism bias’ in contemporary national clinical trial network phase III trials: are we improving?
    Kaveh Zakeri, Sonal Suresh Noticewala, Lucas Kas Vitzthum, E. Sojourner, Hanjie Shen, Loren K. Mell · 2018 · Annals of Oncology
56. Cycle Time Metrics for Multisite Clinical Trials in the United States
    Diana Abbott, Robert M. Califf, Briggs W. Morrison, Christine Pierre, Jean Bolte, Swati Chakraborty · 2013 · Therapeutic Innovation & Regulatory Science
57. Sample size, sample size planning, and the impact of study context: systematic review and recommendations by the example of psychological depression treatment
    Raphael Schuster, Tim Kaiser, Yannik Terhorst, Eva-Maria Meßner, Lucia-Maria Strohmeier, Anton‐Rupert Laireiter · 2021 · Psychological Medicine
58. Characteristics and publication patterns of obstetric studies registered in ClinicalTrials.gov
    Chris R. Stockmann, Catherine M.T. Sherwin, Gideon Koren, Sarah Campbell, Jonathan E. Constance, Matthew W. Linakis, Alfred H. Balch, Michael Walter Varner, Michael G. Spigarelli · 2013 · The Journal of Clinical Pharmacology
59. Aggregator: A machine learning approach to identifying MEDLINE articles that derive from the same underlying clinical trial
    Weixiang Shao, Clive Elliott Adams, Aaron Michael Cohen, John M. Davis, Marian S. McDonagh, Sujata Thakurta, Philip S. Yu, Neil R. Smalheiser · 2014 · Methods
60. Cross-sectional and longitudinal analysis of cancer vaccination trials registered on the US Clinical Trials Database demonstrates paucity of immunological trial endpoints and decline in registration since 2008
    Tobias Janowitz, Liangjian Lu, Haixi Yan, Vijay Shyam-Sundar · 2014 · Drug Design Development and Therapy
61. Not so weak PICO: leveraging weak supervision for participants, interventions, and outcomes recognition for systematic review automation.
    Dhrangadhariya, Anjani, Müller, Henning · 2023 · JAMIA Open
62. Characteristics and trends of clinical studies primarily sponsored by China in WHO primary registries between 2009 and 2018: a cross-sectional survey
    Yang Xu, Min Dong, Xuemei Liu · 2020 · BMJ Open
63. Establishing a clinical trials network in nephrology: experience of the Australasian Kidney Trials Network
    Alicia T. Morrish, Carmel Mary Hawley, David Wayne Johnson, Sunil V. Badve, Vlado Perkovic, Donna M. Reidlinger, Alan Cass · 2013 · Kidney International
64. Stakeholders’ views on the ethical challenges of pragmatic trials investigating pharmaceutical drugs
    Shona Kalkman, Ghislaine J. M. W. van Thiel, Diederick E. Grobbee, Anna‐Katharina Meinecke, Mira G. P. Zuidgeest, Johannes J. M. van Delden · 2016 · Trials
65. Current status of Bayesian clinical trials for oncology, 2020
    Fors, Martha, González, Paloma · 2020 · Contemporary Clinical Trials Communications
66. Recent randomized controlled trials of psychological interventions in healthcare: A review of their quantity, scope, and characteristics
    Filip K. Arnberg, Iman Alaie, Thomas Parling, Ulf Jonsson · 2013 · Journal of Psychosomatic Research
67. Regulatory processes involved in clinical trials and intellectual property rights around vaccine development
    Nimeet Desai, Shreya Pande, Amol Dilip Gholap, Dhwani Rana, Sagar Salave, Lalitkumar K. Vora · 2024 · Elsevier eBooks
68. Developing timely insights into comparative effectiveness research with a text-mining pipeline
    Mei‐Ping Chang, Man Chang, J. Z. Reed, David Milward, Jinghai James Xu, Wendy D. Cornell · 2016 · Drug Discovery Today
69. Assessing the Impact of US Food and Drug Administration Breakthrough Therapy Designation Timing on Trial Characteristics and Development Speed
    Lisette Pregelj, Damian Charles Hine, Aaron Seth Kesselheim, Jonathan J. Darrow · 2021 · Clinical Pharmacology & Therapeutics
70. Use of ClinicalTrials.gov to Estimate Condition-Specific Nocebo Effects and Other Factors Affecting Outcomes of Analgesic Trials
    M. Soledad Cepeda, Victor S. Lobanov, Jesse A. Berlin · 2013 · Journal of Pain
71. The use and reporting of patient-reported outcomes in phase III breast cancer trials
    Remy Leigh Brim, Steven D. Pearson · 2013 · Clinical Trials
72. ClinicalTrials.gov: An Underutilized Source of Research Data About the Design and Conduct of Commercial Clinical Trials
    Harold E. Glass, Lucas M. Glass, Jeffrey J. DiFrancesco · 2014 · Therapeutic Innovation & Regulatory Science
73. Meta-analysis
    Athina Tatsioni, John P. A. Ioannidis · 2016 · Elsevier eBooks
74. Current State of Hypertrophic Cardiomyopathy Clinical Trials
    Hussein H. Khachfe, Hamza A. Salhab, Mohamad Y. Fares, Hassan M. Khachfe · 2019 · Global Heart
75. Sponsorship of oncology clinical trials in the United States according to age of eligibility
    Dylan V. Neel, David Stephen Shulman, Clement Ma, Florence T. Bourgeois, Steven G. DuBois · 2020 · Cancer Medicine
76. Patient-Powered Research Networks of the Autoimmune Research Collaborative: Rationale, Capacity, and Future Directions
    W. Benjamin Nowell, Peter A. Merkel, Robert N McBurney, Kalen Young, Shilpa Venkatachalam, Dianne G. Shaw, Angela Dobes, Emily Cerciello, Laura Kolaczkowski, Jeffrey R. Curtis et al. · 2021 · Patient
77. Geographic and socioeconomic access disparities to Phase 3 clinical trials in ophthalmology in the United States
    Rebecca Russ Soares, Charles Huang, James E. Sharpe, Lucy Cobbs, Anand D. Gopal, Winnie Rao, Annika G. Samuelson, Devayu A. Parikh, Qiang Zhang, Robert S. Bailey et al. · 2022 · Eye
78. Implementing a National Cancer Clinical Trials System for the 21st Century: Workshop Summary
    Sharyl J. Nass, Margie Patlak · 2011
79. Portfolio of prospective clinical trials including brachytherapy: an analysis of the ClinicalTrials.gov database
    Nikola Čihorić, Alexandros Tsikkinis, Cristina Gutiérrez Miguélez, Vratislav Strnad, Ivan Soldatović, Pirus Ghadjar, Branislav M. Jeremic, Alan Dal Pra, Daniel M. Aebersold, Kristina Lössl · 2016 · Radiation Oncology
80. Effects of pulsed low-frequency magnetic field therapy on pain intensity in patients with musculoskeletal chronic low back pain: study protocol for a randomised double-blind placebo-controlled trial
    Fuad A Abdulla, Saad M. Alsaadi, Mir Sadat‐Ali, Fahd A. Al-Khamis, Hani A. Alkhawajah, Serigne Lo · 2019 · BMJ Open
81. The Inclusion of Economic Endpoints as Outcomes in Clinical Trials Reported to ClinicalTrials.gov
    Jordan M. Mitchell, Julie Patterson · 2020 · Journal of Managed Care & Specialty Pharmacy
82. Cross-Sectional Analysis of Data from the U.S. Clinical Trials Database Reveals Poor Translational Clinical Trial Effort for Traumatic Brain Injury, Compared with Stroke
    Lucia M. Li, David Krishna Menon, Tobias Janowitz · 2014 · PLoS ONE
83. Promoting Public Awareness and Engagement in Genome Sciences
    Susanne B. Haga, Katie D. Rosanbalm, Larry C. Boles, Genevieve M. Tindall, Troy M. Livingston, Julianne M. O’Daniel · 2013 · Journal of Genetic Counseling
84. Lack of Transparency in Publishing Negative Clinical Trial Results
    Robert Snyder · 2020 · Clinics in Podiatric Medicine and Surgery
85. Overview of registered studies in orthodontics: Evaluation of the ClinicalTrials.gov registry
    Veerasathpurush Allareddy, Sankeerth Rampa, Mohamed I. Masoud, Min Kyeong Lee, Romesh P. Nalliah, Veerajalandhar Allareddy · 2014 · American Journal of Orthodontics and Dentofacial Orthopedics
86. A mistaken confidence in data
    Édouard Machery · 2021 · European Journal for Philosophy of Science
87. Registered Trials on Artificial Intelligence Conducted in Emergency Department and Intensive Care Unit: A Cross-Sectional Study on ClinicalTrials.gov
    Guina Liu, Nian Li, Lingmin Chen, Yi Yang, Yonggang Zhang · 2021 · Frontiers in Medicine
88. Lack of timely accrual information in oncology clinical trials: a cross-sectional analysis
    Aaron Philip Mitchell, Bradford R. Hirsch, Amy P. Abernethy · 2014 · Trials
89. Does assessing the value for money of therapeutic medical devices require a flexible approach?
    Cynthia P Iglesias · 2015 · Expert Review of Pharmacoeconomics & Outcomes Research
90. Managing Incidental Genomic Findings in Clinical Trials: Fulfillment of the Principle of Justice
    Rafael Dal‐Ré, Nicholas Katsanis, Sara Huston, Lisa S. Parker, Carmen Ayuso · 2014 · PLoS Medicine
91. Characteristics of pediatric pulmonary hypertension trials registered on ClinicalTrials.gov
    Jordan D. Awerbach, Richard A. Krasuski, Kevin D. Hill · 2017 · Pulmonary Circulation
92. Characteristics of Clinical Trials relating to COVID‐19 registered at ClinicalTrials.gov
    Yuhui Wang, Qi Xin Zhou, Mengqi Xu, Jian Kang, Yaolong Chen · 2020 · Journal of Clinical Pharmacy and Therapeutics
93. Design a Clinical Research Protocol: Influence of Real-World Setting
    Jonathan Cimino, Claude Braun · 2023 · Healthcare
94. Portfolio of Clinical Research in Adult Cardiovascular Disease as Reflected in ClinicalTrials.gov
    Karen P. Alexander, David F. Kong, Aijing Z. Starr, Judith M. Kramer, Karen Chiswell, Asba Tasneem, Robert M. Califf · 2013 · Journal of the American Heart Association
95. Independent data monitoring committees: Preparing a path for the future
    Connie Ng Hess, Matthew T. Roe, Charles Michael Gibson, Robert J. Temple, Michael J. Pencina, Deborah A. Zarin, Kevin Joseph Anstrom, John Hunter Alexander, Rachel E. Sherman, Fred T. Fiedorek et al. · 2014 · American Heart Journal
96. Review of the registration of clinical trials in UMIN-CTR from 2 June 2005 to 1 June 2010 - focus on Japan domestic, academic clinical trials
    Wentao Tang, Manabu Fukuzawa, Hirono Ishikawa, Kiichiro Tsutani, Takahiro Kiuchi · 2013 · Trials
97. Restoring invisible and abandoned trials: a call for people to publish the findings
    2013 · BMJ
98. Trends of Phase I Clinical Trials in the Latest Ten Years across Five European Countries
    Davide Di Tonno, Caterina Perlin, Anna Chiara Loiacono, Luca Giordano, Laura Martena, Stefano Lagravinese, Federica Rossi, Santo Marsigliante, Michele Maffia, Andrea Falco et al. · 2022 · International Journal of Environmental Research and Public Health
99. Characteristics of Phase IV Clinical Trials in Oncology: An Analysis Using the ClinicalTrials.gov Registry Data
    Brandon Michael Henry, Giuseppe Lippi, Ameen Nasser, Patryk Ostrowski · 2023 · Current Oncology
100. Race and ethnicity reporting and representation in hemophilia clinical trials
     Stacey A. Fedewa, Leonard A. Valentino, Andee Koo, Lorraine A. Cafuir, Duc Quang Tran, Ana G. Antun, Christine L. Kempton · 2024 · Blood Advances